The Latest Breaking News on Pharma

Amgen is focusing deeply on its efforts to treat obesity, the CFO said Wednesday. Amgen stock rose early Thursday.

Pfizer stock is down Tuesday even after the drugmaker reported higher-than-expected Q3 earnings and raised its full-year outlook.

Fewer teenage pregnancies means a population loss for the states, as well as "diminishment of political representation and loss of federal funds."

The pharma market shows promise as gene therapy gains momentum through rapid advancements that address complex diseases and improve treatment options. Given this favorable trend, it could be wise to watch strong pharma stocks such as Vertex Pharmaceuticals (VRTX), Wave Life Sciences (WVE), and Poseida Therapeutics (PSTX). Read more.

Fans have been waiting more than two years for show to return

Starboard took aim at Pfizer in another blow Tuesday, saying the company has failed to deliver on what it called the "best pipeline" ever.

French pharamceutical giant Sanofi has confirmed plans to sell a controlling stake in its over-the-counter unit to a US investment fund, after employment and investment guarantees relieved political controversy.

French drugmaker Sanofi's Monday confirmation that it plans to sell a controlling stake in its over-the-counter unit to a US investment fund sparked a new political backlash, stoked by fears the deal marks a loss of sovereignty over key medications.

Private equity firm CD&R revealed to be in exclusive talks to buy 50% stake in consumer healthcare arm Opella